Among co-stimulatory receptors, members of the tumor necrosis factor receptor superfamily (TNFRSF) (CD30, DR3, GITR, HVEM, OX-40, TNFR3, 4-1BB) have been widely studied for their application in anti-cancer immunotherapy.14 Here, TNFRSF18 is linked to cancer.